Rong Yang

General Practice

2650 Jones Way Ste 24
Simi Valley, CA 93065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

IL-8 receptor signaling as a novel target for angiogenic retinopathies.

IL-8 receptor signaling as a novel target for angiogenic retinopathies.

Journal: Angiogenesis

Published: January 22, 2025

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.

Journal: Ophthalmology science

Published: August 08, 2023

Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation.

Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: May 15, 2021

Cyanine Nanocage Activated by Near-IR Light for the Targeted Delivery of Cyclosporine A to Traumatic Brain Injury Sites.

Cyanine Nanocage Activated by Near-IR Light for the Targeted Delivery of Cyclosporine A to Traumatic Brain Injury Sites.

Journal: Molecular pharmaceutics

Published: August 20, 2020

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors.

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 13, 2019

The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

Journal: Experimental eye research

Published: July 13, 2019

Targeted Imaging of VCAM-1 mRNA in a Mouse Model of Laser-Induced Choroidal Neovascularization Using Antisense Hairpin-DNA-Functionalized Gold-Nanoparticles.

Targeted Imaging of VCAM-1 mRNA in a Mouse Model of Laser-Induced Choroidal Neovascularization Using Antisense Hairpin-DNA-Functionalized Gold-Nanoparticles.

Journal: Molecular pharmaceutics

Published: October 24, 2018

Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization.

Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization.

Journal: Molecular therapy. Methods & clinical development

Published: September 10, 2018

In Vivo Imaging of Retinal Hypoxia Using HYPOX-4-Dependent Fluorescence in a Mouse Model of Laser-Induced Retinal Vein Occlusion (RVO).

In Vivo Imaging of Retinal Hypoxia Using HYPOX-4-Dependent Fluorescence in a Mouse Model of Laser-Induced Retinal Vein Occlusion (RVO).

Journal: Investigative ophthalmology & visual science

Published: July 28, 2017

Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury.

Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury.

Journal: Science advances

Published: March 07, 2017

Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity.

Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity.

Journal: Scientific reports

Published: March 02, 2017

In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy.

In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy.

Journal: Scientific reports

Published: April 21, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026